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Grand Forks, ND, USA
Deficits in skeletal muscles contribute not only to the functional decline in people
living with Alzheimer’s disease (AD), but also to AD pathogenesis. We have shown
that endolysosome dysfunction plays an important role in the development of AD
pathological features in a cholesterol-fed rabbit model of AD. Interestingly we observed
in skeletal muscle from the rabbit AD model increased deposition of Aβ, phosphorylated
tau, and ubiquitin. Here, we tested the hypothesis that endolysosome dysfunction
commonly occurs in skeletal muscle and brain in this rabbit model of AD. In
skeletal muscle of rabbits fed a 2% cholesterol-enriched diet for 12 weeks we
observed the presence of abnormally enlarged endolysosomes, in which were increased
accumulations of free cholesterol and multiple AD marker proteins subject to misfolding
and aggregation including Aβ, phosphorylated tau, and ubiquitin. Moreover, in skeletal
muscle of rabbits fed the cholesterol-enriched diet we observed decreased specific
activities of three different lysosome enzymes. Our results suggest that elevated levels
of plasma cholesterol can disturb endolysosome structure and function as well as
promote the development of AD-like pathological features in skeletal muscle and that
these organellar changes might contribute to the development of skeletal muscle deficits
in AD.
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INTRODUCTION
Alzheimer’s disease (AD) is the most common neurodegenerative disorder of old age that results in
massive health care costs in the United States (Hebert et al., 2013). AD is characterized clinically by
a progressive cognitive impairment and pathologically by neurodegeneration and the presence of
amyloid plaques composed of amyloid beta (Aβ) protein and neurofibrillary tangles composed of
phosphorylated tau (Holtzman et al., 2011; Goate and Hardy, 2012). Besides neurodegeneration
and cognitive impairment, AD patients often exhibit loss of muscle mass and reduced muscle
strength, and such deficits in skeletal muscle may be early signs of AD and as such these deficits may
help predict the onset and progression of clinical AD (Buchman et al., 2007; Boyle et al., 2009; Burns
et al., 2010). Furthermore, skeletal muscle dysfunction can lead to progressive functional problems
in AD patients and some have proposed that these changes may be not only concordant to those
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occurring in brain, but also that the skeletal muscle changes may
serve as a potential biomarker for the onset and progression of
AD (4–6). Although it is not known how such skeletal muscle
deficits are developed in AD, a testable hypothesis is that common
pathogenic processes occur in brain as well as skeletal muscle
and that these changes may help explain observations of elevated
levels of Aβ in skeletal muscle of AD patients (Kuo et al.,
2000).
Altered cholesterol homeostasis in general and elevated
plasma LDL cholesterol in specific continues to represent robust
risk factors of sporadic AD (Solomon et al., 2009; Chen et al.,
2010; Lesser et al., 2011; Hui et al., 2012; Reed et al., 2014).
Others and we have shown that rabbits fed a cholesterol-enriched
diet exhibit pathological hallmarks of AD including increased
levels of Aβ, phosphorylated tau, and synaptic disruption
(Sparks et al., 1994; Ghribi et al., 2006; Chen et al., 2010).
Mechanistically, we demonstrated in such rabbits that elevated
levels of plasma cholesterol disrupted blood–brain barrier
integrity (Ghribi, 2006; Chen et al., 2008a), increased brain
levels and the neuronal endolysosome accumulation of apoB
(the exclusive apolipoprotein of LDL cholesterol that is normally
found only in the periphery), disturbed the structure and
function of neuronal endolysosomes, and led to the appearance
of pathological features of AD including disrupted synaptic
integrity, brain deposition of Aβ, and tau pathology (Chen
et al., 2010). Thus, LDL cholesterol coming from the systemic
circulation might be altering neuronal endolysosome function
and contributing to the pathogenesis of AD. Furthermore,
using primary cultured neurons, we demonstrated that LDL
cholesterol treatment increased endolysosome accumulation of
cholesterol, enlarged the sizes and numbers of endolysosomes,
and elevated endolysosome pH (Hui et al., 2012). Moreover,
we demonstrated that such alterations in the structure and
function of endolysosomes were directly involved in Aβ
deposition, tau pathology, and disrupted synaptic integrity
(Hui et al., 2012). Thus, our findings suggest strongly that
elevated levels of LDL cholesterol contribute to pathogenesis
of AD by disturbing the structure and function of neuronal
endolysosomes.
Cholesterol for neurons is supplied by astrocyte-derived
lipoproteins. Similarly, cholesterol for skeletal muscle is supplied
by plasma lipoproteins (Spady and Dietschy, 1983). Extracellular
cholesterol, mainly in the form of LDL particles, is delivered into
muscle cells via receptor-mediated endocytosis and transported
to endolysosomes (Brown and Goldstein, 1986). Importantly,
we have shown that the same cholesterol-fed rabbits that
develop AD-like pathology in brain (Chen et al., 2010)
exhibit increased deposition of Aβ and phosphorylated tau
in skeletal muscle fibers (Chen et al., 2008b). Because of the
link between LDL cholesterol and endolysosomes and because
altered endolysosome dysfunction plays an important and
early role in the pathogenesis of AD (Nixon, 2005; Rajendran
et al., 2008; Shimizu et al., 2008; Sannerud et al., 2011;
Wolfe et al., 2013), we hypothesize that elevated levels of
plasma LDL cholesterol disturb the structure and function of
endolysosomes and promotes to the development of AD-like
pathological features in skeletal muscle thus contributing to the
skeletal muscle deficit observed in AD. Herein, we report that
cholesterol-enriched diet induced morphological and functional
changes of endolysosomes as well as abnormal accumulations of
ubiquitin, phosphorylated tau, and Aβ/AβPP in skeletal muscle
endolysosomes.
MATERIALS AND METHODS
Rabbits
New Zealand white female rabbits (1.5 to 2 years old) weighing 3
to 4 kg were fed either normal chow (n = 5) or a normal chow
supplemented with 2% cholesterol (n = 9). After 12 weeks on
the diet, animals were anesthetized and euthanized, and skeletal
muscle (triceps) was dissected, frozen on liquid nitrogen cooled
surface, and stored at −80◦C until taken for experimentation.
The animal protocol was approved by the University of North
Dakota Animal Care and Use Committee adherent with the
Guide for the Care and Use of Laboratory Animals (NIH
publication number 80–23).
Immunohistochemistry
Cryostat-sectioned skeletal muscle (thickness 14 µm) was
stained for target proteins using antibodies to EEA1 (Santa
Cruz, sc-0415), LAMP2 (Santa Cruz, sc-8101), cathepsin D
(Sigma, c0715), Aβ (4G8, Signet, 39220), phosphorylated tau
(SMI-31, Covance, 141815001), ubiquitin (Santa Cruz, sc-8017),
N-terminal AβPP (Chemicon, MAB348), C-terminal AβPP
(Sigma, A8717), and microtubule-associated protein light chain
3 (LC3, Santa cruz, sc-16755). For immunohistochemistry
for bright field microscopy, sections were developed with
diaminobenzidine substrate using the avidin-biotin horseradish
peroxidase system (Vector Laboratories) and counterstained
with hematoxylin, and bright field images were taken by a
Nikon Eclipse 80i (upright) microscope with a 40× PlanApo
objective. Double fluorescence staining was used to determine
co-localization of early endosome marker (EEA1, Abcam
ab70521) with late endosome/lysosome marker (LAMP2, Santa
Cruz, sc-8101) or autophagosome marker (LC3, Santa cruz,
sc-16755) and subcellular co-distribution patterns of AβPP,
Aβ, phosphorylated tau, and ubiquitin in early endosome
EEA1 (Santa Cruz, sc-0415) and lysosomes (LAMP2, Santa
Cruz, sc-8101) or autophagosomes (LC3, Santa cruz, sc-
16755). Sections were examined by an Olympus FV300 laser
scanning confocal microscope: Argon laser (488 nm, 10 mW)
and HeNe laser (543 nm, 1 mW), external two-channel
photomultiplier detection, FITC and Texas red probes, 60× oil
PlanApo objective, Spot RT color CCD camera, and Fluoview
software. Free cholesterol was stained with filipin (Sigma) and
co-distribution of free cholesterol with endolysosomes was
examined with a Leica DM4000B fluorescent microscope: 63×
oil HCX PL Fluotar objective, DAPI and Texas red filters,
Leica SCR camera, Leica Application Suite software. Images
were process by Image J software or Photoshop CS5 software.
Controls for specificity were used including staining muscle
with an isotype-matched irrelevant antibody as a negative
control, staining muscle with primary antibodies without
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fluorescence-conjugated secondary antibodies (background
controls), and staining muscle with only secondary antibodies –
these controls allowed us to eliminate auto-fluorescence
in each channel and bleed-through (crossover) between
channels.
Immunoblotting
Skeletal muscle was homogenized mechanically in TPER
extraction buffer (Pierce) at a ratio of 1:20 (w:v) in the
presence of protease inhibitor cocktail (Sigma) and phosphatase
inhibitors (5 mmol/l sodium fluoride and 50 µmol/l sodium
orthovanadate). The detergent-soluble fraction (supernatant)
was isolated by centrifugation at 100,000 × g for 1 h
at 4◦C. Protein concentration was determined by Bradford
assay. Equal amounts of protein (100 µg) from detergent-
soluble fractions were resolved by SDS-PAGE under reducing
conditions, transferred to PVDF membranes, and subjected to
immunoblotting with antibodies to N-terminal AβPP (1:1000,
Chemicon, MAB348), phosphorylated tau (AT8, 1: 1000,
Pierce, MN1020), tau 5 (1:1000, Calbiochem 577801), acid
phosphatase (1:1000, Abcam, ab54720), cathepsin D (1:1000,
Sigma, C0715), cathepsin B (1:1000, Sigma, C6243), Aβ (6E10,
1:500, Signet, 9320), and LC3 was detected using an anti-
LC3 antibody (which recognizes both LC3-I and LC3-II,
1:500, Abcam, ab58610). Blots were probed with secondary
antibodies conjugated with horseradish peroxidase (HRP) for
1 h at room temperature, reacted with luminal reagent,
exposed, visualized, and analyzed by LabWorks 4.5 software
on a UVP Bioimaging System (Upland). Quantification was
performed by densitometry and the results were analyzed
and normalized (vs. averaged densitometric volume values of
control rabbits). Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH, 1:5000, Abcam, ab8245) was used for loading
controls.
Lysosomal Enzyme Activity
Measurement
Acid phosphatase enzyme activity was determined using an
Acid Phosphatase Assay kit (Sigma); a luminescence-based
assay that uses 4-nitrophenyl phosphate as the substrate
(Chen et al., 2010). Enzyme activities of cathepsin D and
cathepsin B were determined using two separate assay kits
(BioVision); fluorescence-based assays that use preferred MCA-
labeled substrates for cathepsin-D and cathepsin B (Chen
et al., 2010). Enzyme activities were expressed as relative
opitcal density or fluorescence units (RFU) per 50 µg of total
protein. Specific activities of each enzyme were indicated by
the ratio of enzyme activity to protein levels as determined by
immunoblotting
Statistical Analysis
All data were expressed as mean and SEM. Statistical significance
was determined with unpaired two-tail Student’s t-test
(Frequentist tests indicated that all data were normally
distributed). P < 0.05 was considered to be statistically
significant.
RESULTS
Cholesterol-Enriched Diet Increases
Accumulation of Cholesterol in
Endolysosomes and Disturbs
Endolysosome Structure and Function
Skeletal muscle has a very low capacity to synthesize cholesterol
(Spady and Dietschy, 1983) and it meets its cholesterol needs
mainly by taking up circulating lipoproteins. Extracellular
cholesterol in the form of LDL is delivered into muscle
cells via receptor-mediated endocytosis and transported to
endolysosomes (Brown and Goldstein, 1986). In our cholesterol-
fed rabbits, serum levels of cholesterol were about 10-times higher
than normal (Chen et al., 2008b). Because LDL cholesterol is
endocytosed in skeletal muscle, we examined the extent to which
cholesterol was accumulated in endolysosomes. Using double
fluorescence staining techniques with EEA1 as a marker for
endosomes, filipin for free cholesterol, and LAMP2 for lysosomes,
we found that filipin-positive staining of free cholesterol co-
distributed with EEA1-positive endosomes (Figure 1A) and
LAMP2-positive lysosomes (Figure 1B). None of these features
were present in muscle from control rabbits. In addition,
we found that EEA1-positive endosomes and LAMP2-positive
lysosomes appeared to be enlarged (Figures 1A,B). To access
further endolysosome morphological changes we stained for
EEA1, LAMP2, and the lysosomal enzyme cathepsin D and
found under light microscopy that endolysosome-positive
signals (EEA1, LAMP2, and cathepsin D) were weak and
diffuse in muscle from control rabbits, but endolysosome-
positive staining was readily observed and appeared as large
specifically stained aggregates in muscles from cholesterol-fed
rabbits (Figure 1C). Furthermore, we found that the percentage
of muscle fibers that contained such abnormally enlarged
endolysosomes was 2.5 ± 0.6% (% to total muscle fibers
examined). The percentage of impaired muscle fibers seems
low, however, it is induced by cholesterol diet treatment for
only 3 months. With longer treatment, we expect more muscle
fibers will be affected, and this could have a significant impact
for the pathogenesis of sporadic AD, which take decades to
develop.
It is not clear how such abnormally enlarged endolysosomes
are developed; however, based on recent findings that EEA1
positive early endosomes could fuse with lysosomes under
disrupted endocytic homeostasis (Falcon-Perez et al., 2005;
Das and Pellett, 2011; Ramanathan et al., 2013), the observed
abnormally enlarged endolysosomes in cholesterol fed rabbits
could result from uncontrolled fusion of endosomes with
late endolysosome/lysosomes. As such, we determined the
co-localization of EEA1 with LAMP2, and we found that
EEA1 is co-localized with LAMP2 in those abnormally
enlarged endolysosomes in muscle fibers from cholesterol-fed
rabbits (Figure 1D). These findings suggest that increased
cholesterol uptake and subsequent endolysosome accumulation
of cholesterol in skeletal muscle could disrupt endocytic
homeostasis and lead to uncontrolled fusion of early endosomes
with late endosomes/lysosomes.
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FIGURE 1 | Cholesterol-enriched diet increases accumulation of free cholesterol in endolysosomes and induces endolysosome enlargement.
(A,B) Filipin-positive staining of free cholesterol (blue) co-distributed with EEA1-positive endosomes (red) and LAMP2-positive lysosomes (red) in muscle from
cholesterol-fed rabbits. (C) In muscle fibers from control rabbits, EEA1, LAMP2, and cathepsin D staining appeared weak and diffuse, but in muscle fibers from
cholesterol-fed rabbits, EEA1, LAMP2, and cathepsin D positive staining was strong forming large clumps (40X). (D) Cholesterol-enriched diet increased
co-localization of EEA1 with LAMP2 in those abnormally enlarged endolysosomes. Bar = 20 µm.
Because of the above findings that cholesterol-enriched diet
induced increases in cholesterol accumulation and endolysosome
enlargement, we determined next the extent to which cholesterol-
enriched diet affected endolysosome function by measuring
protein levels and specific activities of three different enzymes;
cathepsin D, cathepsin B, and acid phosphatase. We found
that the cholesterol-enriched diet increased significantly protein
levels of acid phosphatase (Figure 2A, p < 0.05), cathepsin D
(Figure 2C, p < 0.05), and cathepsin B (Figure 2E, p < 0.01),
but decreased significantly the specific enzyme activity (ratio of
enzyme activity to protein levels) of acid phosphatase (Figure 2B,
p < 0.05), cathepsin D (Figure 2D, p < 0.05), and cathepsin
B (Figure 2F, p < 0.01). Together, these findings indicate
that the cholesterol-enriched diet increased the accumulation
of cholesterol in endolysosomes and altered the structure and
function of endolysosomes in skeletal muscle. As a reminder,
we would like to point out that such endolysosome changes are
similar to those reported by others in brain neurons from AD
patients (Cataldo and Nixon, 1990; Cataldo et al., 1994, 2000) and
by us in brains of cholesterol-fed rabbits (Chen et al., 2010).
Cholesterol-Enriched Diet Increases the
Accumulation of Phosphorylated tau,
Ubiquitin, and AβPP in Endolysosomes
Multiple proteins that tend to aggregate including
phosphorylated tau (Alonso et al., 1996; Alonso Adel et al.,
2013; Wang et al., 2013), Aβ (Braak and Del Tredici, 2004;
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FIGURE 2 | Cholesterol-enriched diet impairs specific activities of endolysosome enzymes. Representative western blots were shown. The
cholesterol-enriched diet (n = 9) increased significantly protein levels of acid phosphatase (A, ∗p < 0.05), cathepsin D (C, ∗p < 0.05), and cathepsin B (E,
∗∗p < 0.01) in skeletal muscle, when compared with controls (n = 5). Cholesterol-enriched diet (n = 9) decreased significantly specific activities (ratio of total enzyme
activity to protein levels as determined by immunoblotting) of acid phosphatase (B, ∗p < 0.05), cathepsin D (D, ∗p < 0.05), and cathepsin B (F, ∗∗p < 0.01), when
compared with controls (n = 5).
LaFerla et al., 2007), and ubiquitin (Dil Kuazi et al., 2003)
are increasingly accumulated in neurons of individuals living
with AD. We have shown that these proteins are accumulated
in neurons of rabbits fed a cholesterol-enriched diet (Chen
et al., 2010). More importantly, we showed previously that
these same proteins were also deposited in skeletal muscle of
rabbits fed the cholesterol-enriched diet (Chen et al., 2008b). In
addition, all these proteins have been linked to endolysosomes;
amyloidogenic processing of AβPP has been shown to occur
mainly in endolysosomes following AβPP endocytosis (Nixon,
2005; Rajendran and Annaert, 2012; Morel et al., 2013; Jiang
et al., 2014), ubiquitin has been shown to function as a signal for
membrane protein internalization and protein degradation in the
autophagy-lysosome system (Holler and Dikic, 2004; D’Agostino
et al., 2011), and tau and phosphorylated tau have been reported
to be degraded in the autophagy-lysosome system (Kenessey
et al., 1997; Oyama et al., 1998; Hamano et al., 2008; Wang et al.,
2009; Chesser et al., 2013). As described above, we demonstrated
that cholesterol-fed rabbits markedly enlarged endolysosomes
and disturbed their function in skeletal muscle. Thus, we
determined next the extent to which cholesterol-enriched diet
affected accumulation of these proteins in endolysosomes in
skeletal muscle of rabbits fed a cholesterol-enriched diet.
To access endolysosome accumulation of tau protein, we
stained phosphorylated tau and found under bright field
microscopy that SMI-31 positive phosphorylated tau signals
were weak in muscle from control rabbits, but SMI-31 positive
phosphorylated tau signals was readily observed and appeared
as large aggregates in muscles from cholesterol-fed rabbits
(Figure 3A). The size and shape of these phosphorylated tau-
positive signals were similar to those endolysosome-positive
signals (Figure 1C), indicating the phosphorylated tau might
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FIGURE 3 | Cholesterol-enriched diet increases the accumulation of phosphorylated tau in endolysosomes. (A) In muscle fibers from control rabbits,
SMI-31 positive staining was weak, but in muscle fibers from cholesterol-fed rabbits SMI-31 positive staining appeared as large aggregates (40X). (B) SMI-31
positive staining of phosphorylated tau (red) co-distributed with EEA1-positive staining of endosomes (green) and LAMP2-positive staining of lysosomes (green) in
muscle from cholesterol-fed rabbits. Bar = 20 µm. (C) Representative western blots were shown. Rabbits fed cholesterol-enriched diet (n = 9) exhibited significantly
(∗p < 0.05) increased protein levels of phosphorylated tau in skeletal muscle, when compared with controls (n = 5).
be accumulating in abnormally enlarged endolysosomes.
Using double fluorescence staining methods, we found that
intramuscular depositions of phosphorylated tau were co-
distributed with EEA1-positive endosomes and LAMP2-positive
lysosomes (Figure 3B). Our findings are consistent with others’
reports that tau and phosphorylated tau can be degraded in the
autophagy-lysosome system (Kenessey et al., 1997; Oyama et al.,
1998; Hamano et al., 2008; Wang et al., 2009; Chesser et al., 2013).
Although tau and phosphorylated tau are not normally present in
early endosomes, under conditions when endocytic homeostasis
is disrupted with uncontrolled fusion of early endosomes with
late endosomes/lysosomes (Figure 1D) it is possible for tau
to be co-localized with EEA1 positive early endosomes. These
morphological data suggest that cholesterol-enriched diet
promotes the intramuscular accumulation of phosphorylated tau
in abnormally enlarged endolysosomes. To extend and confirm
further our observations, we examined next protein levels of
phosphorylated tau using immunoblotting methods. We found
significantly increased protein levels of phosphorylated tau
(Figure 3C, p < 0.05) in skeletal muscle from cholesterol-fed
rabbits when compared to those from control rabbits. Thus our
data suggest that cholesterol-enriched diet leads to an increased
accumulation of phosphorylated tau in abnormally enlarged
endolysosomes in skeletal muscle.
To access endolysosome accumulation of ubiquitin, we
stained ubiquitin and found under bright field microscopy that
ubiquitin positive signals were weak in muscle from control
rabbits, but ubiquitin positive staining was readily observed and
appeared as large aggregates in muscles from cholesterol-fed
rabbits (Figure 4A). The size and shape of these ubiquitin positive
signals were also similar to those endolysosome-positive signals
(Figure 1C), indicating the ubiquitin might be accumulating
in abnormally enlarged endolysosomes. Using double
fluorescence staining methods, we found that intramuscular
depositions of ubiquitin were co-distributed with EEA1-positive
endosomes and LAMP2-positive lysosomes (Figure 4B).
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FIGURE 4 | Cholesterol-enriched diet increases the accumulation of ubiquitin in endolysosomes. (A) In muscle fibers from control rabbits, ubiquitin positive
staining was weak, but in muscle fibers from cholesterol-fed rabbits ubiquitin positive staining appeared as large aggregates (40X). (B) Ubiquitin positive staining (red)
co-distributed with EEA1-positive staining of endosomes (green) and with LAMP2-positive staining of lysosomes (green) in muscle from cholesterol-fed rabbits.
Bar = 20 µm. (C) Representative western blots were shown. Rabbits fed cholesterol-enriched diet (n = 9) exhibited significantly (∗∗∗P < 0.001) increased protein
levels of ubiquitin in skeletal muscle, when compared with controls (n = 5).
These morphological data suggest that ubiquitin accumulates
intramuscularly in abnormally enlarged endolysosomes, which
are consistent with others’ reports that ubiquitin functions
as a signal for membrane protein internalization and protein
degradation in the autophagy-lysosome system (Holler and
Dikic, 2004; D’Agostino et al., 2011). To extend and confirm
further our observations, we examined next protein levels
of ubiquitin using immunoblotting methods. We found
significantly increased protein levels of ubiquitin (Figure 4C,
p < 0.001) in skeletal muscle from cholesterol-fed rabbits when
compared to those from control rabbits. Thus, our data suggest
that cholesterol-enriched diet leads to an increased accumulation
of ubiquitin in abnormally enlarged endolysosomes in skeletal
muscle. The presence of ubiquitin positive inclusions indicate
a general degeneration process is occurring. To assess whether
such general degeneration might be involved in the pathogenesis
of Parkinson’s disease or amyotrophic lateral sclerosis, we
determined the expression of α-synuclein and TPD-43
using immunohistochemistry. We found positive but weak
immunopositive staining for α-synuclein and TPD-43 in
impaired muscle fibers (Supplementary Data). These findings
are consistent with our findings that cholesterol-enriched diet
induces a general degeneration process as evidenced by the
presence of ubiquitin positive inclusions. However, given the
weak staining signals for α-synuclein and TPD-43, it is not
likely that cholesterol-enriched diet plays a significant or specific
pathological role in the development of Parkinson’s disease or
amyotrophic lateral sclerosis.
To access endolysosome accumulation of AβPP protein, we
stained AβPP with a N-terminal AβPP antibody or a C-terminal
AβPP antibody (data not shown) and found under bright field
microscopy that AβPP positive signals were mainly present
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at plasma membrane and intramuscular signals were weak
in muscle from control rabbits, but AβPP positive signals
were readily observed and appeared as large aggregates inside
muscles from cholesterol-fed rabbits (Figure 5A). The size
and shape of these AβPP positive signals were also similar to
those endolysosome-positive signals (Figure 1C), indicating
the AβPP might be accumulating in abnormally enlarged
endolysosomes. Using double fluorescence staining methods,
we found that intramuscular depositions of AβPP were
co-distributed with EEA1-positive endosomes and LAMP2-
positive lysosomes (Figure 5B). These morphological data
suggest that AβPP accumulates intramuscularly in abnormally
enlarged endolysosomes. To extend and confirm further
our observations, we examined next protein levels of AβPP
using immunoblotting methods. We found significantly
increased protein levels of AβPP (Figure 5C, p < 0.01) in
skeletal muscle from cholesterol-fed rabbits when compared
to those from control rabbits. Thus, our data suggest that
cholesterol-enriched diet leads to an increased accumulation
of AβPP in abnormally enlarged endolysosomes in skeletal
muscle.
Aβ Accumulates in Endosomes and
Autophagosomes in Skeletal Muscle of
Rabbits Fed Cholesterol-Enriched Diet
Endolysosomes play a critical role in amyloidogenic processing
of AβPP (Rajendran and Annaert, 2012; Morel et al., 2013; Jiang
et al., 2014) and they are major sites where Aβ is generated
following internalization of AβPP (Nixon, 2005; Rajendran et al.,
2008; Shimizu et al., 2008; Sannerud et al., 2011; Rajendran
and Annaert, 2012; Morel et al., 2013; Jiang et al., 2014). Once
generated, Aβ can be degraded by cathepsins in lysosomes
(Miners et al., 2011) and the remaining Aβ can either accumulate
in endolysosomes where it may precipitate AD pathogenesis
(Braak and Del Tredici, 2004; LaFerla et al., 2007; Zou et al.,
2015) or it can be released via exocytosis (Annunziata et al., 2013;
Nilsson et al., 2013). Accordingly, Aβ levels can be enhanced by
those factors that promote amyloidogenic processing of AβPP
(Grbovic et al., 2003; Ma et al., 2009) and those that impair Aβ
degradation (Torres et al., 2012).
Given our findings that cholesterol enriched diet increases
cholesterol accumulation in endolysosomes and dramatically
FIGURE 5 | Cholesterol-enriched diet increases the accumulation of AβPP in endolysosomes. (A) In muscle fibers from control rabbits, N-terminal AβPP
positive signals were mainly present at plasma membrane and intramuscular signals were weak, but in muscles from cholesterol-fed rabbits AβPP positive signals
appeared as large aggregates inside muscles (40X). (B) N-terminal AβPP positive staining (red) co-distributed with EEA1-positive staining of endosomes (green) and
with LAMP2-positive staining of lysosomes (green) in muscle from cholesterol-fed rabbits. Bar = 20 µm. (C) Representative western blots were shown. Rabbits fed
cholesterol-enriched diet (n = 9) exhibited significantly (∗∗P < 0.01) increased protein levels of AβPP in skeletal muscle, when compared with controls (n = 5).
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FIGURE 6 | Cholesterol-enriched diet increases deposition of Aβ in endosomes and autophagosomes. (A) In muscle fibers from control rabbits, 4G8
positive Aβ signals were weak, but in muscles from cholesterol-fed rabbits 4G8 positive Aβ signals appeared as large aggregates inside muscles (40X).
(B) Representative western blots were shown. Cholesterol-enriched diet (n = 9) increased significantly protein levels of Aβ oligomers (∗p < 0.05) in skeletal muscle,
when compared with controls (n = 5). (C) 4G8-positive staining of Aβ (red) co-distributed with EEA1 positive staining of endosomes (green) in skeletal muscle from
cholesterol-fed rabbits. Bar = 20 µm. (D) In muscle fibers from control rabbits, LC3 positive autophagosome signals were weak and diffuse, but appeared as large
aggregates inside muscles from cholesterol-fed rabbits (40X). (E) Representative western blots were shown. Cholesterol-enriched diet (n = 9) increased significantly
protein levels of LC3-II (∗∗p < 0.01) in skeletal muscle, when compared with controls (n = 5). (F) 4G8-positive staining of Aβ (red) co-distributed with LC3-positive
staining for autophagosomes (green) in skeletal muscle from cholesterol-fed rabbits. Bar = 20 µm. (G) EEA1positive endosomes (green) co-distributed with
LC3-positive staining for autophagosomes (red) in skeletal muscle from cholesterol-fed rabbits. Bar = 20 µm.
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altered structure and function of endolysosomes, we determined
the extent to which cholesterol-enriched diet affects levels
of intramuscular Aβ. Using the 4G8 antibody for detection
of Aβ, we found under bright field microscopy that 4G8
positive Aβ signals appeared as large aggregates inside
muscles from cholesterol-fed rabbits (Figure 6A). Using
immunoblotting methods, we found that cholesterol-enriched
diet increased significantly protein levels of Aβ oligomers
(Figure 6B, p < 0.05) in skeletal muscle from cholesterol-
fed rabbits. Using double fluorescent staining, we found
that 4G8-positive Aβ staining co-distributed with EEA1-
positive endosomes (Figure 6C), a finding consistent with
endosome production of Aβ. None of these features was
present in skeletal muscle of control rabbits. Our observations
of increased accumulation of Aβ/AβPP in endolysosomes
suggests to us that increased amyloidogenic processing of AβPP
was caused by morphological and functional alterations in
endolysosomes.
Because Aβ was also found to be a substrate for autophagy
(Nixon, 2007), we next determined the extent to which
Aβ accumulated in autophagosomes. We found under light
microscopy that LC3 positive autophagosome signals were
weak and diffuse in muscles from control rabbits, but
appeared as large aggregates inside muscles from cholesterol-
fed rabbits (Figure 6D). Using immunoblotting methods, we
found that cholesterol-enriched diet increased significantly
protein levels of LC3-II, an indicator of autophagosome
proliferation and maturation (Figure 6E, p < 0.01). Using
double fluorescent staining, we found that 4G8-positive Aβ
staining co-distributed with LC3 positive autophagosomes
(Figure 6F). The observation that Aβ is present in LC3-positive
autophagosomes suggests further the presence of dysfunctional
endolysosome-autophagosome system. Given our finding that
cholesterol-enriched diet increases the co-localization of EEA1
with LAMP2 (Figure 1D), which indicates endolysosome
accumulation of cholesterol could lead to uncontrolled fusion of
early endosomes with late endosome/lysosomes, we determined
the extent to which cholesterol-enriched diet affects the co-
localization of EEA1 with LC3. We found that cholesterol-
enriched diet increased dramatically co-localization of EEA1
with LC3 (Figure 6G). These observations indicate that
endolysosome accumulation of cholesterol could also increase
fusion of early endosomes with autophagosome, a phenomenon
that fosters maturation of autophagosomes (Tooze and Razi,
2009).
DISCUSSION
The present studies were aimed to test the hypothesis
that endolysosome dysfunction in skeletal muscle shares
common pathological features to those found in brain in a
rabbit model of sporadic AD. Principally, we demonstrated
that skeletal muscle from a cholesterol-fed rabbit model
of AD exhibited increased cholesterol accumulation in
endolysosomes, enlarged endolysosomes, and impaired
endolysosome function. Furthermore, we demonstrated
that various AD marker proteins including phosphorylated tau,
ubiquitin, AβPP and Aβ were accumulated in those enlarged
endolysosomes. Together these findings provide further insight
into skeletal muscle involvement in AD and the potentially
significant role that endolysosomes play in the pathogenesis
of AD.
Endolysosomes are acidic organelles consisting of endosomes,
lysosomes, and autophagosomes that play a key role in protein
turnover and cellular homeostasis (Appelqvist et al., 2013).
Substrates for degradation are delivered to lysosomes by two
general routes namely endocytosis and autophagy. Endocytosis
is responsible for up-taking extracellular nutrients as well as
turnover of plasma membrane proteins. Autophagy, on the
other hand, is responsible for removing intracellular protein
aggregates and “worn out” organelles. Endolysosomes are
especially important for physiological functions of neurons and
skeletal muscle cells because they are long-lived post-mitotic
cells that require efficient endolysosomes to degrade intracellular
protein aggregates, eliminate “worn out” organelles and maintain
membrane integrity. As such, endolysosome dysfunction in
neurons has been linked to neurodegeneration and has been
shown to play an early and important role in the development
of AD (Cataldo et al., 2000; Nixon, 2005; Rajendran et al.,
2008; Shimizu et al., 2008; Sannerud et al., 2011). Similarly,
endolysosome dysfunction in skeletal muscle contributes to
muscle degeneration and age-related disorders and has been
implicated in a variety of autophagosome and lysosome related
myopathies (Askanas et al., 2009; Nogalska et al., 2010; Malicdan
and Nishino, 2012; Bonaldo and Sandri, 2013; Demontis et al.,
2013; Sandri et al., 2013). Interestingly, skeletal muscle deficits
such as loss of muscle mass and reduced muscle strength
has been shown to be early signs of AD that contribute
to disability and could predict the onset and progression of
clinical AD (Buchman et al., 2007; Boyle et al., 2009; Burns
et al., 2010). However, the question of whether endolysosome
dysfunction leads to development of pathological features of AD
in skeletal muscle and contributes to skeletal muscle deficits
in AD has not been addressed. As such, we determined the
extent to which elevated levels of plasma LDL cholesterol,
a robust risk factor for AD, disturbed the structure and
function of endolysosomes and promoted the development of
AD-like pathological features including intracellular deposition
of Aβ/AβPP, phosphorylated tau, and ubiquitin in skeletal
muscle.
Given that plasma lipoproteins supply skeletal muscle with
needed cholesterol (Spady and Dietschy, 1983), elevated plasma
LDL cholesterol and subsequent increases in LDL cholesterol
uptake could lead to increased cholesterol accumulation in
endolysosomes and disturbed endolysosome structure and
dysfunction. As expected, we demonstrated cholesterol-enriched
diet increased free cholesterol in endosomes and lysosomes in
skeletal muscle. Importantly, we demonstrated that cholesterol-
enriched diet dramatically enlarged endolysosomes and inhibited
endolysosome function. Our observations that cholesterol-
enriched diet increased co-localization of EEA1 with LAMP2
and LC3 indicate that abnormally enlarged endolysosomes
might result from uncontrolled fusion of early endosomes
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with late endosome/lysosomes or autophagosomes, a finding
that is consistent with recent reports that EEA1 positive early
endosomes could fuse with lysosomes under disrupted endocytic
homeostasis (Falcon-Perez et al., 2005; Das and Pellett, 2011;
Ramanathan et al., 2013).
The observations that cholesterol enriched diet increased
accumulation of Aβ/AβPP in endolysosomes suggest to us
that increased amyloidogenic processing of AβPP was caused
by morphological and functional alterations in endolysosomes.
The observation that Aβ is also present in LC3-positive
autophagosomes suggests further the presence of dysfunctional
endolysosomes because autophagic activity itself is part of
the endolysosome system. Elevated levels of LDL cholesterol
could promote Aβ deposition in skeletal muscle in two
ways. First, receptor-mediated endocytosis of LDL cholesterol
could encourage the accumulation of AβPP in endolysosomes
by either promoting AβPP internalization (Waldron et al.,
2006, 2008; Klug et al., 2011) or impairing the recycling of
internalized AβPP back to plasma membrane (Andersen et al.,
2005; Willnow and Andersen, 2013). Second, endolysosome
inhibition could lead to impairment of Aβ degradation in
lysosomes because Aβ can be degraded in lysosomes by
cathepsin D and B (Nogalska et al., 2012; Saido and Leissring,
2012). Our observations that cholesterol-enriched diet increases
endolysosome accumulation of AβPP and decreased specific
enzyme activities of cathepsin D and B support, at least indirectly,
both possible mechanisms.
The observations that cholesterol-enriched diet increased
accumulation of ubiquitin and phosphorylated tau in
endolysosomes in skeletal muscle indicate that endolysosome
dysfunction as induced by a cholesterol-enriched diet contributes
to the development of AD-like ubiquitin-positive multi-protein
aggregates and inclusions in skeletal muscle. These findings are
consistent with other’s reports that increased accumulation of
cholesterol in lysosomes and subsequent lysosome dysfunction
has been linked to the development of neurofibrillary tangles in
brains of patients with Niemann-Pick type C disease (Sawamura
et al., 2001; Bu et al., 2002; Distl et al., 2003; Vance, 2006;
Bi and Liao, 2007; Liao et al., 2007) and our reports that
endolysosome dysfunction as induced by high levels of LDL
cholesterol contributes to the development of tau-pathology in
neurons (Chen et al., 2010; Hui et al., 2012).
Although a causal relationship is not determined, our
findings do suggest that endolysosome dysfunction as induced
by elevated plasma LDL cholesterol, aging, or other factors
may play a pathogenic role in the development of AD-like
pathological changes observed in skeletal muscle, similar to
its role in neurodegeneration and the pathogenesis of AD
in brain. Furthermore, our findings support the notion that
common pathogenic mechanisms may exist in skeletal muscle
and neurons, and that the skeletal muscle changes may represent
early and progressive pathological features of AD.
AUTHOR CONTRIBUTIONS
XC, OG, and JG contributed to design the work. XC and JW
contributed to the acquisition and analysis of data. XC drafted the
work. XC, JW, OG, and JG contributed to interpretation of data
and revising the work of intellectual content and final approval
of the version to be published. XC drafted the work. XC, JW, OG,
and JG approved of the final version and agreed to be accountable
for all aspects of the work in ensuring that questions related to
the accuracy or integrity of any part of the work are appropriately
investigated and resolved.
FUNDING
This work was supported by P30GM103329, R01MH100972, and
R01MH105329.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fnagi.
2016.00129
REFERENCES
Alonso, A. C., Grundke-Iqbal, I., and Iqbal, K. (1996). Alzheimer’s disease
hyperphosphorylated tau sequesters normal tau into tangles of filaments and
disassembles microtubules. Nat. Med. 2, 783–787. doi: 10.1038/nm0796-783
Alonso Adel, C., ElAkkad, E., Gong, C., Liu, F., Tanaka, T., Kudo, T., et al.
(2013). Inge Grundke-Iqbal, Ph.D. (1937–2012): the discoverer of the abnormal
hyperphosphorylation of tau in Alzheimer’s disease. J. Mol. Neurosci. 49, 430–
435. doi: 10.1007/s12031-012-9925-z
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J.,
et al. (2005). Neuronal sorting protein-related receptor sorLA/LR11 regulates
processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 102,
13461–13466. doi: 10.1073/pnas.0503689102
Annunziata, I., Patterson, A., Helton, D., Hu, H., Moshiach, S., Gomero, E., et al.
(2013). Lysosomal NEU1 deficiency affects amyloid precursor protein levels and
amyloid-beta secretion via deregulated lysosomal exocytosis. Nat. Commun. 4,
2734. doi: 10.1038/ncomms3734
Appelqvist, H., Waster, P., Kagedal, K., and Ollinger, K. (2013). The lysosome:
from waste bag to potential therapeutic target. J. Mol. Cell Biol. 5, 214–226. doi:
10.1093/jmcb/mjt022
Askanas, V., Engel, W. K., and Nogalska, A. (2009). Inclusion body myositis: a
degenerative muscle disease associated with intra-muscle fiber multi-protein
aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased
lysosomal degradation. Brain Pathol. 19, 493–506. doi: 10.1111/j.1750-
3639.2009.00290.x
Bi, X., and Liao, G. (2007). Autophagic-lysosomal dysfunction and
neurodegeneration in Niemann-Pick Type C mice: lipid starvation or
indigestion? Autophagy 3, 646–648. doi: 10.4161/auto.5074
Bonaldo, P., and Sandri, M. (2013). Cellular and molecular mechanisms of muscle
atrophy. Dis. Model Mech. 6, 25–39. doi: 10.1242/dmm.010389
Boyle, P. A., Buchman, A. S., Wilson, R. S., Leurgans, S. E., and Bennett, D. A.
(2009). Association of muscle strength with the risk of Alzheimer disease
and the rate of cognitive decline in community-dwelling older persons. Arch.
Neurol. 66, 1339–1344. doi: 10.1001/archneurol.2009.240
Braak, H., and Del Tredici, K. (2004). Alzheimer’s disease: intraneuronal alterations
precede insoluble amyloid-beta formation. Neurobiol. Aging 25, 713–718;
discussion 743–716. doi: 10.1016/j.neurobiolaging.2003.12.015
Brown, M. S., and Goldstein, J. L. (1986). A receptor-mediated pathway
for cholesterol homeostasis. Science 232, 34–47. doi: 10.1126/science.
3513311
Frontiers in Aging Neuroscience | www.frontiersin.org 11 June 2016 | Volume 8 | Article 129
fnagi-08-00129 June 6, 2016 Time: 16:37 # 12
Chen et al. AD-Like Pathology in Rabbit Muscle
Bu, B., Li, J., Davies, P., and Vincent, I. (2002). Deregulation of cdk5,
hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C
murine model. J. Neurosci. 22, 6515–6525.
Buchman, A. S., Boyle, P. A., Wilson, R. S., Tang, Y., and Bennett, D. A. (2007).
Frailty is associated with incident Alzheimer’s disease and cognitive decline in
the elderly. Psychosom. Med. 69, 483–489. doi: 10.1097/psy.0b013e318068de1d
Burns, J. M., Johnson, D. K., Watts, A., Swerdlow, R. H., and Brooks, W. M. (2010).
Reduced lean mass in early Alzheimer disease and its association with brain
atrophy. Arch. Neurol. 67, 428–433. doi: 10.1001/archneurol.2010.38
Cataldo, A. M., Hamilton, D. J., and Nixon, R. A. (1994). Lysosomal
abnormalities in degenerating neurons link neuronal compromise to senile
plaque development in Alzheimer disease. Brain Res. 640, 68–80. doi:
10.1016/0006-8993(94)91858-9
Cataldo, A. M., and Nixon, R. A. (1990). Enzymatically active lysosomal proteases
are associated with amyloid deposits in Alzheimer brain. Proc. Natl. Acad. Sci.
U.S.A. 87, 3861–3865. doi: 10.1073/pnas.87.10.3861
Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., and
Nixon, R. A. (2000). Endocytic pathway abnormalities precede amyloid beta
deposition in sporadic Alzheimer’s disease and Down syndrome: differential
effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157, 277–286.
doi: 10.1016/S0002-9440(10)64538-5
Chen, X., Gawryluk, J. W., Wagener, J. F., Ghribi, O., and Geiger, J. D. (2008a).
Caffeine blocks disruption of blood brain barrier in a rabbit model of
Alzheimer’s disease. J. Neuroinflammation 5, 12. doi: 10.1186/1742-2094-5-12
Chen, X., Ghribi, O., and Geiger, J. D. (2008b). Rabbits fed cholesterol-
enriched diets exhibit pathological features of inclusion body myositis. Am. J.
Physiol. Regul. Integr. Comp. Physiol. 294, R829–R835. doi: 10.1152/ajpregu.
00639.2007
Chen, X., Wagener, J. F., Morgan, D. H., Hui, L., Ghribi, O., and Geiger, J. D. (2010).
Endolysosome mechanisms associated with Alzheimer’s disease-like pathology
in rabbits ingesting cholesterol-enriched diet. J. Alzheimers Dis. 22, 1289–1303.
doi: 10.3233/JAD-2010-101323
Chesser, A. S., Pritchard, S. M., and Johnson, G. V. (2013). Tau clearance
mechanisms and their possible role in the pathogenesis of Alzheimer disease.
Front. Neurol. 4:122. doi: 10.3389/fneur.2013.00122
D’Agostino, C., Nogalska, A., Cacciottolo, M., Engel, W. K., and Askanas, V.
(2011). Abnormalities of NBR1, a novel autophagy-associated protein, in
muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol. 122,
627–636. doi: 10.1007/s00401-011-0874-3
Das, S., and Pellett, P. E. (2011). Spatial relationships between markers for secretory
and endosomal machinery in human cytomegalovirus-infected cells versus
those in uninfected cells. J. Virol. 85, 5864–5879. doi: 10.1128/JVI.00155-11
Demontis, F., Piccirillo, R., Goldberg, A. L., and Perrimon, N. (2013). Mechanisms
of skeletal muscle aging: insights from Drosophila and mammalian models. Dis.
Model Mech. 6, 1339–1352. doi: 10.1242/dmm.012559
Dil Kuazi, A., Kito, K., Abe, Y., Shin, R. W., Kamitani, T., and Ueda, N. (2003).
NEDD8 protein is involved in ubiquitinated inclusion bodies. J. Pathol. 199,
259–266. doi: 10.1002/path.1283
Distl, R., Treiber-Held, S., Albert, F., Meske, V., Harzer, K., and Ohm, T. G. (2003).
Cholesterol storage and tau pathology in Niemann-Pick type C disease in the
brain. J. Pathol. 200, 104–111. doi: 10.1002/path.1320
Falcon-Perez, J. M., Nazarian, R., Sabatti, C., and Dell’Angelica, E. C.
(2005). Distribution and dynamics of Lamp1-containing endocytic organelles
in fibroblasts deficient in BLOC-3. J. Cell Sci. 118, 5243–5255. doi:
10.1242/jcs.02633
Ghribi, O. (2006). Preservation of the blood brain barrier integrity may underlie
neuroprotective effects of statins in Alzheimer’s disease. J. Alzheimers Dis. 10,
407–408.
Ghribi, O., Larsen, B., Schrag, M., and Herman, M. M. (2006). High cholesterol
content in neurons increases BACE, beta-amyloid, and phosphorylated
tau levels in rabbit hippocampus. Exp. Neurol. 200, 460–467. doi:
10.1016/j.expneurol.2006.03.019
Goate, A., and Hardy, J. (2012). Twenty years of Alzheimer’s disease-
causing mutations. J. Neurochem. 120(Suppl. 1), 3–8. doi: 10.1111/j.1471-
4159.2011.07575.x
Grbovic, O. M., Mathews, P. M., Jiang, Y., Schmidt, S. D., Dinakar, R.,
Summers-Terio, N. B., et al. (2003). Rab5-stimulated up-regulation of the
endocytic pathway increases intracellular beta-cleaved amyloid precursor
protein carboxyl-terminal fragment levels and Abeta production. J. Biol. Chem.
278, 31261–31268. doi: 10.1074/jbc.M304122200
Hamano, T., Gendron, T. F., Causevic, E., Yen, S. H., Lin, W. L., Isidoro, C.,
et al. (2008). Autophagic-lysosomal perturbation enhances tau aggregation
in transfectants with induced wild-type tau expression. Eur. J. Neurosci. 27,
1119–1130. doi: 10.1111/j.1460-9568.2008.06084.x
Hebert, L. E., Weuve, J., Scherr, P. A., and Evans, D. A. (2013). Alzheimer disease
in the United States (2010-2050) estimated using the 2010 census. Neurology 80,
1778–1783. doi: 10.1212/WNL.0b013e31828726f5
Holler, D., and Dikic, I. (2004). Receptor endocytosis via ubiquitin-dependent
and -independent pathways. Biochem. Pharmacol. 67, 1013–1017. doi:
10.1016/j.bcp.2004.01.003
Holtzman, D. M., Morris, J. C., and Goate, A. M. (2011). Alzheimer’s disease:
the challenge of the second century. Sci. Transl. Med. 3:77sr71. doi:
10.1126/scitranslmed.3002369
Hui, L., Chen, X., and Geiger, J. D. (2012). Endolysosome involvement in LDL
cholesterol-induced Alzheimer’s disease-like pathology in primary cultured
neurons. Life Sci. 91, 1159–1168. doi: 10.1016/j.lfs.2012.04.039
Jiang, S., Li, Y., Zhang, X., Bu, G., Xu, H., and Zhang, Y. W. (2014). Trafficking
regulation of proteins in Alzheimer’s disease. Mol. Neurodegener. 9, 6. doi:
10.1186/1750-1326-9-6
Kenessey, A., Nacharaju, P., Ko, L. W., and Yen, S. H. (1997). Degradation
of tau by lysosomal enzyme cathepsin D: implication for Alzheimer
neurofibrillary degeneration. J. Neurochem. 69, 2026–2038. doi: 10.1046/j.1471-
4159.1997.69052026.x
Klug, W., Dietl, A., Simon, B., Sinning, I., and Wild, K. (2011). Phosphorylation
of LRP1 regulates the interaction with Fe65. FEBS Lett. 585, 3229–3235. doi:
10.1016/j.febslet.2011.09.028
Kuo, Y. M., Kokjohn, T. A., Watson, M. D., Woods, A. S., Cotter, R. J., Sue,
L. I., et al. (2000). Elevated abeta42 in skeletal muscle of Alzheimer disease
patients suggests peripheral alterations of AbetaPP metabolism. Am. J. Pathol.
156, 797–805. doi: 10.1016/S0002-9440(10)64947-4
LaFerla, F. M., Green, K. N., and Oddo, S. (2007). Intracellular amyloid-beta in
Alzheimer’s disease. Nat. Rev. Neurosci. 8, 499–509. doi: 10.1038/nrn2168
Lesser, G. T., Beeri, M. S., Schmeidler, J., Purohit, D. P., and Haroutunian, V.
(2011). Cholesterol and LDL relate to neuritic plaques and to APOE4 presence
but not to neurofibrillary tangles. Curr. Alzheimer Res. 8, 303–312. doi:
10.2174/156720511795563755
Liao, G., Yao, Y., Liu, J., Yu, Z., Cheung, S., Xie, A., et al. (2007).
Cholesterol accumulation is associated with lysosomal dysfunction and
autophagic stress in Npc1 -/- mouse brain. Am. J. Pathol. 171, 962–975. doi:
10.2353/ajpath.2007.070052
Ma, Q. L., Galasko, D. R., Ringman, J. M., Vinters, H. V., Edland, S. D.,
Pomakian, J., et al. (2009). Reduction of SorLA/LR11, a sorting protein
limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
Arch. Neurol. 66, 448–457. doi: 10.1001/archneurol.2009.22
Malicdan, M. C., and Nishino, I. (2012). Autophagy in lysosomal myopathies. Brain
Pathol. 22, 82–88. doi: 10.1111/j.1750-3639.2011.00543.x
Miners, J. S., Barua, N., Kehoe, P. G., Gill, S., and Love, S. (2011). Abeta-degrading
enzymes: potential for treatment of Alzheimer disease. J. Neuropathol. Exp.
Neurol. 70, 944–959. doi: 10.1097/NEN.0b013e3182345e46
Morel, E., Chamoun, Z., Lasiecka, Z. M., Chan, R. B., Williamson, R. L.,
Vetanovetz, C., et al. (2013). Phosphatidylinositol-3-phosphate regulates
sorting and processing of amyloid precursor protein through the endosomal
system. Nat. Commun. 4, 2250. doi: 10.1038/ncomms3250
Nilsson, P., Loganathan, K., Sekiguchi, M., Matsuba, Y., Hui, K., Tsubuki, S., et al.
(2013). Abeta secretion and plaque formation depend on autophagy. Cell Rep.
5, 61–69. doi: 10.1016/j.celrep.2013.08.042
Nixon, R. A. (2005). Endosome function and dysfunction in Alzheimer’s disease
and other neurodegenerative diseases. Neurobiol. Aging 26, 373–382. doi:
10.1016/j.neurobiolaging.2004.09.018
Nixon, R. A. (2007). Autophagy, amyloidogenesis and Alzheimer disease. J. Cell
Sci. 120, 4081–4091. doi: 10.1242/jcs.019265
Nogalska, A., D’Agostino, C., Engel, W. K., and Askanas, V. (2012). Activation
of the gamma-secretase complex and presence of gamma-secretase-
activating protein may contribute to Abeta42 production in sporadic
inclusion-body myositis muscle fibers. Neurobiol. Dis. 48, 141–149. doi:
10.1016/j.nbd.2012.06.008
Frontiers in Aging Neuroscience | www.frontiersin.org 12 June 2016 | Volume 8 | Article 129
fnagi-08-00129 June 6, 2016 Time: 16:37 # 13
Chen et al. AD-Like Pathology in Rabbit Muscle
Nogalska, A., D’Agostino, C., Terracciano, C., Engel, W. K., and Askanas, V. (2010).
Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic
reticulum stress-provoked cultured human muscle fibers. Am. J. Pathol. 177,
1377–1387. doi: 10.2353/ajpath.2010.100050
Oyama, F., Murakami, N., and Ihara, Y. (1998). Chloroquine myopathy suggests
that tau is degraded in lysosomes: implication for the formation of paired helical
filaments in Alzheimer’s disease. Neurosci. Res. 31, 1–8. doi: 10.1016/S0168-
0102(98)00020-0
Rajendran, L., and Annaert, W. (2012). Membrane trafficking pathways in
Alzheimer’s disease. Traffic 13, 759–770. doi: 10.1111/j.1600-0854.2012.
01332.x
Rajendran, L., Schneider, A., Schlechtingen, G., Weidlich, S., Ries, J., Braxmeier, T.,
et al. (2008). Efficient inhibition of the Alzheimer’s disease beta-secretase by
membrane targeting. Science 320, 520–523. doi: 10.1126/science.1156609
Ramanathan, H. N., Zhang, G., and Ye, Y. (2013). Monoubiquitination of EEA1
regulates endosome fusion and trafficking. Cell Biosci. 3, 24. doi: 10.1186/2045-
3701-3-24
Reed, B., Villeneuve, S., Mack, W., DeCarli, C., Chui, H. C., and Jagust, W. (2014).
Associations between serum cholesterol levels and cerebral amyloidosis. JAMA
Neurol. 71, 195–200. doi: 10.1001/jamaneurol.2013.5390
Saido, T., and Leissring, M. A. (2012). Proteolytic degradation of
amyloid beta-protein. Cold Spring Harb. Perspect. Med. 2:a006379. doi:
10.1101/cshperspect.a006379
Sandri, M., Coletto, L., Grumati, P., and Bonaldo, P. (2013). Misregulation of
autophagy and protein degradation systems in myopathies and muscular
dystrophies. J. Cell Sci. 126, 5325–5333. doi: 10.1242/jcs.114041
Sannerud, R., Declerck, I., Peric, A., Raemaekers, T., Menendez, G., Zhou, L., et al.
(2011). ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein
(APP) processing by mediating the endosomal sorting of BACE1. Proc. Natl.
Acad. Sci. U.S.A. 108, E559–E568. doi: 10.1073/pnas.1100745108
Sawamura, N., Gong, J. S., Garver, W. S., Heidenreich, R. A., Ninomiya, H.,
Ohno, K., et al. (2001). Site-specific phosphorylation of tau accompanied
by activation of mitogen-activated protein kinase (MAPK) in brains
of Niemann-Pick type C mice. J. Biol. Chem. 276, 10314–10319. doi:
10.1074/jbc.M009733200
Shimizu, H., Tosaki, A., Kaneko, K., Hisano, T., Sakurai, T., and Nukina, N.
(2008). Crystal structure of an active form of BACE1, an enzyme responsible
for amyloid beta protein production. Mol. Cell. Biol. 28, 3663–3671. doi:
10.1128/MCB.02185-07
Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., and Whitmer, R. A. (2009).
Midlife serum cholesterol and increased risk of Alzheimer’s and vascular
dementia three decades later. Dement. Geriatr. Cogn. Disord. 28, 75–80. doi:
10.1159/000231980
Spady, D. K., and Dietschy, J. M. (1983). Sterol synthesis in vivo in 18 tissues of the
squirrel monkey, guinea pig, rabbit, hamster, and rat. J. Lipid Res. 24, 303–315.
Sparks, D. L., Scheff, S. W., Hunsaker, J. C. III, Liu, H., Landers, T., and Gross,
D. R. (1994). Induction of Alzheimer-like beta-amyloid immunoreactivity in
the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88–94. doi:
10.1006/exnr.1994.1044
Tooze, S. A., and Razi, M. (2009). The essential role of early endosomes in
autophagy is revealed by loss of COPI function. Autophagy 5, 874–875. doi:
10.4161/auto.9066
Torres, M., Jimenez, S., Sanchez-Varo, R., Navarro, V., Trujillo-Estrada, L.,
Sanchez-Mejias, E., et al. (2012). Defective lysosomal proteolysis and axonal
transport are early pathogenic events that worsen with age leading to increased
APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus. Mol.
Neurodegener. 7, 59. doi: 10.1186/1750-1326-7-59
Vance, J. E. (2006). Lipid imbalance in the neurological disorder, Niemann-Pick C
disease. FEBS Lett. 580, 5518–5524. doi: 10.1016/j.febslet.2006.06.008
Waldron, E., Heilig, C., Schweitzer, A., Nadella, N., Jaeger, S., Martin, A. M.,
et al. (2008). LRP1 modulates APP trafficking along early compartments of the
secretory pathway. Neurobiol. Dis. 31, 188–197. doi: 10.1016/j.nbd.2008.04.006
Waldron, E., Jaeger, S., and Pietrzik, C. U. (2006). Functional role of the low-density
lipoprotein receptor-related protein in Alzheimer’s disease. Neurodegener. Dis.
3, 233–238. doi: 10.1159/000095261
Wang, J. Z., Xia, Y. Y., Grundke-Iqbal, I., and Iqbal, K. (2013). Abnormal
hyperphosphorylation of tau: sites, regulation, and molecular mechanism of
neurofibrillary degeneration. J. Alzheimers Dis. 33(Suppl. 1), S123–S139. doi:
10.3233/JAD-2012-129031
Wang, Y., Martinez-Vicente, M., Kruger, U., Kaushik, S., Wong, E., Mandelkow,
E. M., et al. (2009). Tau fragmentation, aggregation and clearance: the
dual role of lysosomal processing. Hum. Mol. Genet. 18, 4153–4170. doi:
10.1093/hmg/ddp367
Willnow, T. E., and Andersen, O. M. (2013). Sorting receptor SORLA–a
trafficking path to avoid Alzheimer disease. J. Cell Sci. 126, 2751–2760. doi:
10.1242/jcs.125393
Wolfe, D. M., Lee, J. H., Kumar, A., Lee, S., Orenstein, S. J., and Nixon, R. A. (2013).
Autophagy failure in Alzheimer’s disease and the role of defective lysosomal
acidification. Eur. J. Neurosci. 37, 1949–1961. doi: 10.1111/ejn.12169
Zou, C., Montagna, E., Shi, Y., Peters, F., Blazquez-Llorca, L., Shi, S., et al. (2015).
Intraneuronal APP and extracellular Abeta independently cause dendritic
spine pathology in transgenic mouse models of Alzheimer’s disease. Acta
Neuropathol. 129, 909–920. doi: 10.1007/s00401-015-1421-4
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Chen, Wagener, Ghribi and Geiger. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 13 June 2016 | Volume 8 | Article 129
